Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Journal of Clinical Pharmacology|November 1, 1996
Lack of pharmacokinetic interaction after administration of lansoprazole or omeprazole with prednisoneJ H Cavanaugh, M D KarolClinical Pharmacology and Therapeutics|November 1, 1981
Beta-blocking effect of single oral doses of carteololR W Stoll, J H Cavanaugh, C M MacLeodJournal of Clinical Pharmacology|March 10, 2000
Lack of interaction between lansoprazole and propranolol, a pharmacokinetic and safety assessmentM D Karol, C S Locke, J H CavanaughJournal of Clinical Pharmacology|December 10, 1999
Lack of pharmacokinetic interaction between lansoprazole and intravenously administered phenytoinM D Karol, C S Locke, J H CavanaughClinical Pharmacokinetics|January 1, 1995
Lack of pharmacokinetic interaction between zileuton and phenytoin in humansE Samara, J H Cavanaugh, D Mukherjee, et al.The Journal of Clinical Investigation|August 1, 1970
Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in manJ R Mitchell, J H Cavanaugh, L Arias, et al.Journal of Clinical Pharmacology|May 1, 1997
Evaluation of the diurnal variation in the pharmacokinetics of zileuton in healthy volunteersW M Awni, C Locke, L M Dube, et al.Clinical Pharmacology and Therapeutics|October 1, 1977
Trials with an adenosine analogue as antianginal medicationF Irshad, G R Dagenais, E J Fedor, et al.Clinical Therapeutics|May 1, 1995
Lansoprazole: an alternative method of administration of a capsule dosage formulationA H Chun, C J Eason, H H Shi, et al.Journal of Clinical Pharmacology|May 1, 1997
Effect of valproate on the pharmacokinetics and pharmacodynamics of lorazepamE E Samara, R G Granneman, G F Witt, et al.Pageof 4